-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Epinephrine in Infectious Rhinitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Epinephrine in Infectious Rhinitis Drug Details: Epinephrine (ARS-1) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Tesidolumab in Non-infectious Uveitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tesidolumab in Non-infectious Uveitis Drug Details: Tesidolumab (LFG-316) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Optiquel in Non-infectious Uveitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Optiquel in Non-infectious Uveitis Drug Details:Optiquel (Peptide B27PD) is under development for the treatment of chronic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ESK-001 in Non-infectious Uveitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ESK-001 in Non-infectious Uveitis Drug Details: ESK-001 is under development for the treatment of systemic lupus...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Satralizumab in Autoimmune Encephalitis (Post-Infectious)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Satralizumab in Autoimmune Encephalitis (Post-Infectious) Drug Details: Satralizumab (Enspryng) is a humanized monoclonal antibody. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Laquinimod Sodium in Non-infectious Uveitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Laquinimod Sodium in Non-infectious Uveitis Drug Details: Laquinimod sodium (ABR-215062) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Brepocitinib Tosylate in Non-infectious Uveitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Brepocitinib Tosylate in Non-infectious Uveitis Drug Details: Brepocitinib tosylate is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TLL-041 in Autoimmune Encephalitis (Post-Infectious)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TLL-041 in Autoimmune Encephalitis (Post-Infectious) Drug Details: BHV-8000 (TLL-041) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Recombinant Plasma Gelsolin Replacement for Infectious Disease in Sepsis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Recombinant Plasma Gelsolin Replacement for Infectious Disease in Sepsis Drug Details: Recombinant plasma gelsolin (pGSN)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MRNA-1189 in Mononucleosis (Infectious Mononucleosis, Glandular Fever)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.MRNA-1189 in Mononucleosis (Infectious Mononucleosis, Glandular Fever)Drug Details:mRNA-1189 is under development for the prevention of infectious...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.